Quick Summary
Moderna experienced a 10% decline Thursday following Wednesday’s extraordinary 177% surge tied to promising cancer vaccine trial results
Cryptocurrency equities including Coinbase, Robinhood, and Strategy posted significant gains following President Trump’s congressional appeal for crypto regulation
Bitcoin surged beyond 9% to approximately $71,000, marking its strongest performance since early June
Walmart shares tumbled 6.1% despite increasing annual projections, which failed to meet Wall Street’s expectations
Webull soared 14% following disclosure of record-breaking Q2 revenue totaling $198.8M, representing 51% annual growth
Shares of Moderna experienced significant downward pressure Thursday morning, declining approximately 10% before market open. The pharmaceutical stock’s retreat followed an extraordinary 177% rally on Wednesday, triggered by encouraging clinical trial data for its melanoma cancer vaccine developed in partnership with Merck.
The clinical data demonstrated the vaccine’s potential to prevent cancer recurrence and metastasis. Market analysts pointed to profit-taking activity as the primary driver behind Thursday’s correction following Wednesday’s dramatic gains.
Cryptocurrency Equities Surge Following Presidential Legislative Appeal
Coinbase advanced 8%, Robinhood climbed 5.8%, and Strategy registered a 10% increase Thursday. These gains materialized after President Donald Trump urged congressional action on comprehensive cryptocurrency legislation.
Bitcoin’s value increased over 9% to approximately $71,000, representing its strongest level since June 2. The rally received additional momentum from the U.S. Treasury Department’s announcement to expand planned repurchases of longer-maturity Treasury securities to a minimum of $4 billion per transaction, resulting in decreased long-term bond yields.
Circle Internet Group advanced 5%, while both Riot Platforms and Mara Holdings registered gains ranging from 3% to 5%. The entire cryptocurrency sector experienced widespread upward movement.
Walmart Declines Despite Quarterly Performance
Walmart shares declined 6.1% despite announcing increased full-year projections. The market’s negative reaction stemmed from the company’s revised outlook remaining below analyst consensus estimates, eclipsing an otherwise solid second-quarter earnings performance.
Alibaba retreated 1.9% after delivering fiscal first quarter results that underperformed analyst forecasts, despite reporting robust artificial intelligence revenue expansion.
Webull emerged as one of Thursday’s top performers, surging 14%. The digital brokerage platform announced all-time high Q2 revenue reaching $198.8M, surpassing analyst projections of $180.7M. The company’s equity trading activity increased 73% compared to the prior year.
Ultragenyx Pharmaceutical advanced 12% following FDA accelerated approval for Genglycos, its gene therapy treatment for glycogen storage disease. The regulatory clearance establishes Genglycos as the inaugural therapy targeting the root cause of this uncommon metabolic condition.
Wolfspeed declined 10% after disclosing a quarterly loss exceeding analyst projections. The company’s adjusted loss per share reached $2.26 compared to the consensus forecast of $1.47.
Coty retreated approximately 9% to 10% after announcing a larger-than-anticipated loss. The cosmetics corporation projected declining revenue and adjusted gross margin for the upcoming quarter.
Deere defied the broader negative sentiment, gaining 1.2% following better-than-forecast fiscal third quarter financial results.
Index futures faced headwinds Thursday as escalating Middle Eastern geopolitical tensions drove Brent crude prices above $92 per barrel, maintaining inflation anxieties among market participants.
The post Thursday’s Stock Market Highlights: Walmart (WMT) Tumbles, Moderna (MRNA) Slides, Crypto Equities Soar appeared first on Blockonomi.